Phase 2b open label randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania. (Trial Acronym NAC Trial).
Phytochemical analysis of Acacia nilotica and evaluation of its antileishmanial potential
Efficacy of vafidemstat in experimental autoimmune encephalomyelitis highlights the KDM1A/RCOR1/HDAC epigenetic axis in multiple sclerosis
Althaea officinalis extracts heal skin wounds in second- and third-degree burns in mice
An ancient motif unique for human STING, RGS12 and SARS-CoV-2 spike proteins
Hot Spot Mapping and Size Estimation of Illicit Drug Users in Iran: A Pilot Study
Sodium Diethyldithiocarbamate Antiparasitic Activity Against Different Trypanosoma Cruzi Strains: Insights of Its Biological Activity
Effects of curcumin and its nanomicelle form on body weight, insulin resistance, adiponectin, and blood parameters of streptozotocin-induced diabetic rats
Cortical oscillations to measure anti-epileptic drug activity in clinical trials
Label-Free High-Throughput Screening Assay for the Identification of Norepinephrine Transporter (NET / SLC6A2) Inhibitors